1. An early glimpse at azacitidine plus venetoclax for myelodysplastic syndromes. Issue 10 (October 2022) Authors: Pleyer, Lisa; Sekeres, Mikkael A Journal: Lancet Issue: Volume 9:Issue 10(2022) Page Start: e714 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications. Issue 1 (December 2016) Authors: Pleyer, Lisa; Burgstaller, Sonja; Stauder, Reinhard; Girschikofsky, Michael; Sill, Heinz; Schlick, Konstantin; Thaler, Josef; Halter, Britta; Machherndl-Spandl, Sigrid; Zebisch, Armin; Pichler, Angelika; Pfeilstöcker, Michael; Autzinger, Eva-Maria; Lang, Alois; Geissler, Klaus; Voskova, Daniela; ... Journal: Journal of hematology & oncology Issue: Volume 9:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Azacitidine in adult patients with acute myeloid leukemia. (August 2017) Authors: Schuh, Andre C.; Döhner, Hartmut; Pleyer, Lisa; Seymour, John F.; Fenaux, Pierre; Dombret, Hervé Journal: Critical reviews in oncology/hematology Issue: Volume 116(2017) Page Start: 159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clonal evolution and heterogeneity in metastatic head and neck cancer—An analysis of the Austrian Study Group of Medical Tumour Therapy study group. (April 2018) Authors: Melchardt, Thomas; Magnes, Teresa; Hufnagl, Clemens; Thorner, Aaron R.; Ducar, Matthew; Neureiter, Daniel; Tränkenschuh, Wolfgang; Klieser, Eckhard; Gaggl, Alexander; Rösch, Sebastian; Rasp, Gerd; Hartmann, Tanja N.; Pleyer, Lisa; Rinnerthaler, Gabriel; Weiss, Lukas; Greil, Richard; Egle, Alexander Journal: European journal of cancer Issue: Volume 93(2018) Page Start: 69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Digging deep into "dirty" drugs – modulation of the methylation machinery. (May 2015) Authors: Pleyer, Lisa; Greil, Richard Journal: Drug metabolism reviews Issue: Volume 47:Number 2(2015:Apr.) Page Start: 252 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL‐2 and/or BIM. (28th February 2019) Authors: Huemer, Florian; Melchardt, Thomas; Jansko, Bettina; Wahida, Adam; Jilg, Stefanie; Jost, Philipp J.; Klieser, Eckhard; Steiger, Katja; Magnes, Teresa; Pleyer, Lisa; Greil‐Ressler, Sigrun; Rass, Christof; Greil, Richard; Egle, Alexander Journal: European journal of haematology Issue: Volume 102:Number 5(2019) Page Start: 437 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. IDO in MDS/AML disease progression and its role in resistance to azacitidine: a potential new drug target?. (17th May 2020) Authors: Leisch, Michael; Greil, Richard; Pleyer, Lisa Journal: British journal of haematology Issue: Volume 190:Number 3(2020) Page Start: 314 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study. Issue 2 (February 2021) Authors: Pleyer, Lisa; Leisch, Michael; Kourakli, Alexandra; Padron, Eric; Maciejewski, Jaroslaw Pawel; Xicoy Cirici, Blanca; Kaivers, Jennifer; Ungerstedt, Johanna; Heibl, Sonja; Patiou, Peristera; Hunter, Anthony Michael; Mora, Elvira; Geissler, Klaus; Dimou, Maria; Jimenez Lorenzo, Maria-José; Melchard... Journal: Lancet Issue: Volume 8:Issue 2(2021) Page Start: e135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Reactivation of dormant anti-tumor immunity – a clinical perspective of therapeutic immune checkpoint modulation. Issue 1 (December 2017) Authors: Greil, Richard; Hutterer, Evelyn; Hartmann, Tanja; Pleyer, Lisa Journal: Cell communication and signaling Issue: Volume 15:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Real life experience with frontline azacitidine in a large series of older adults with acute myeloid leukemia stratified by MRC/LRF score: results from the expanded international E-ALMA series (E-ALMA+). Issue 5 (4th May 2018) Authors: Falantes, José; Pleyer, Lisa; Thépot, Sylvain; Almeida, António M.; Maurillo, Luca; Martínez-Robles, Violeta; Stauder, Reinhard; Itzykson, Raphael; Pinto, Ricardo; Venditti, Adriano; Bargay, Joan; Burgstaller, Sonja; Martínez, María Pilar; Seegers, Valerie; Cortesão, Emilia; Foncillas, María Ánge... Journal: Leukemia & lymphoma Issue: Volume 59:Issue 5(2018) Page Start: 1113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗